Research report on the drugs market of anti-senile dementia
Since 1999, China has been growing into an aging society. With the increase of aging population, incidents of senile dementia have been on the rise. According to conservative estimates, by the end of 2007, patients of senile dementia in China have amounted to 600 million or so. The search for effective drugs for senile dementia has become one of the major concerns of the world’s medical research. This report gives a classification of drugs for senile dementia in correspondence with different categories of the disease and makes an analysis of the market situation of a variety of drugs and drug manufacturers.
1 CLASSIFICATION OF SENILE DEMENTIA
1.1 Senile dementia caused by degenarative brain desease
1.2 Vascular dementia
1.3 Mixed dementia
2 DRUGS FOR SENILE DEMENTIA
2.1 Drugs for Alzheimer's disease(AD)
2.2 Drugs for vascular dementia
2.3 The development of drugs for senile dementia
3 CHINA’S MARKET FOR DRUGS FOR SENILE DEMENTIA
3.1 The market demand for drugs for senile dementia
3.2 China’s Market for drugs for senile dementia
3.3 China’s Market for drugs for vascular dementia(VD)
3.4 Manufacturers of drugs for senile dementia
1.1 Senile dementia caused by degenarative brain desease
1.2 Vascular dementia
1.3 Mixed dementia
2 DRUGS FOR SENILE DEMENTIA
2.1 Drugs for Alzheimer's disease(AD)
2.2 Drugs for vascular dementia
2.3 The development of drugs for senile dementia
3 CHINA’S MARKET FOR DRUGS FOR SENILE DEMENTIA
3.1 The market demand for drugs for senile dementia
3.2 China’s Market for drugs for senile dementia
3.3 China’s Market for drugs for vascular dementia(VD)
3.4 Manufacturers of drugs for senile dementia
